FTC restrains holdcos: Publicis, WPP, and Dentsu must end uniform brand safety rules as regulators probe political bias in ad buying.
Nearly half of US AI users (49%) say they're likely or very likely to try a different brand than usual if an AI assistant suggests one as an alternative, according to a March report from EMARKETER and Publicis Commerce.
In-store retail media is moving beyond pilot programs and becoming a strategic priority for major brands, with leading consumer-packaged goods (CPG) companies now operationalizing campaigns across budgets, teams, and measurement frameworks to reach shoppers where most purchase decisions are made.
This FAQ explores why event marketing is growing, what new technologies are changing the event landscape, and how marketers should approach event strategy in 2026.
Spirit’s potential liquidation underscores fuel shock and airlines’ premium shift.
Inflation fears and fuel risks from the Iran war squeeze retail and discretionary demand.
Price cuts and protein-forward innovation lift volumes, offsetting softer beverage demand.
As Medicare GLP-1 coverage begins, Walmart can capture more weight-care demand from its boomer customer base.
Protest over changes to the retailer’s ad payment policies lay bare merchants’ growing cash flow struggles.
Netflix powers ahead post-WBD: Q1 shows 16% revenue rise as ads are poised to hit $3 billion, proving it can scale without a mega-deal.
As inflationary and wartime pressures rise, consumers are likely to seek value-based rewards and credit products to weather the storm.
Betting on Gen Z-oriented rewards, brands, and celebrity endorsements may carry Venmo’s success.
Real-time payments could help SoFi’s ecosystem push its SoFi Plus membership.
Banks need to redesign how they participate in the homebuying process.
The market is catching up to the moment, and banks that don’t offer at least indirect exposure to crypto risk falling behind.
With AI models like Mythos on the horizon, are they doing enough to defend against emerging risks?
Health plans reduced prior authorizations by 11%, but pressure on insurers remains as the changes risk seeming cosmetic without clear impact on clinicians and patients.
Failing to obtain consent when using AI scribes during medical appointments breaches trust, damages reputations, and risks driving patients away.
Consumers are increasingly turning to AI to overcome cost and access barriers. But because its health advice can be unreliable, provider organizations should guide safe use and offer their own vetted chatbots.
Drug brands invested $1.6B in linear, down 8% QoQ, while NFL and Olympics broadcasts dominated total spending.